GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

Respiratory illnesses like the flu and COVID-19 spread more commonly in the fall and winter months ahead, and doctors in ...

GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.

Dr. Kerry-Anne Perkins, a new mom and board-certified OB-GYN shares what parents need to know about RSV and more.

London Health Sciences Centre is now offering respiratory syncytial virus (RSV) vaccinations to patients who don't have a ...

Influenza and respiratory syncytial virus (RSV) activity in Ontario is expected to increase over the next several days as ...

Britons across the nation are experiencing what they're calling 'the worst cold ever', as this winter's illnesses strike hard ...

About 2.1% of antibiotic prescriptions over the study period were connected to RSV diagnoses, especially in seniors and ...

The UKHSA says that Covid rates decreased slightly last week, but flu cases increased, as did Respiratory Syncytial Virus ...

Respiratory syncytial virus (RSV) immunizations are now available for eligible patients who do not have a primary care provider through Children’s Hospital at London Health Sciences Centre (LHSC). RSV ...

If you’ve had a lingering cough recently, there is a chance the culprit wasn’t Covid-19, flu or RSV, but mycoplasma ...

This update in the health sector highlights major developments including DiaSorin's significant profit growth, GSK's RSV ...